• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOQ

BANK OF QUEENSLAND LIMITED. - News & Media

0.93% ! $7.58
Market Cap $5.013B  !
Financial Services Banks - Global
Add to My Watchlist

Bank of Queensland Limited is an Australia-based regional bank. The principal activity of... Bank of Queensland Limited is an Australia-based regional bank. The principal activity of the Company includes the provision of financial services to the community. The Company’s segments include Retail Banking and BOQ Business. The Retail Bank segment provides retail banking solutions to customers through a network of branches, ME Bank and Virgin Money distribution channels, digital platforms, and third-party intermediaries. The BOQ Business provides business banking solutions, including commercial lending, equipment finance and leasing, cash flow finance, foreign exchange hedging and international transfers, interest rate hedging, transaction banking, home lending and deposit solutions for business customers. Its banking and savings accounts include an everyday account, simple saver account, future saver account, term deposits and smart saver account. It offers home and contents insurance, landlord insurance, and car insurance.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Bank of Queensland (ASX:BOQ) CEO and Managing Director Patrick Allaway retains top job

Bank of Queensland (BOQ) has confirmed that its current CEO and MD Patrick Allaway will continue in his role and that the search for a replacement has been discontinued.

14 Aug 2023 13:29 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$7.58 		Change
0.070(0.93%) 		Mkt cap ! $5.013B
Open High Low Value Volume
$7.50 $7.61 $7.47 $5.581M 737.0K

Buyers (Bids)

No. Vol. Price($)
1 4735 $7.57
 

Sellers (Offers)

Price($) Vol. No.
$7.59 191 2
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
Last
$7.59 		  Change
0.070 ( 0.87 %)
Open High Low Volume
$7.49 $7.61 $7.48 221714
Last updated 15.59pm 30/07/2025 ?
BOQ (ASX) Chart

Top Stories

Ionic Rare Earths falls -7% as momentum slips on vague production update

Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.